-
Lannett receives approval for generic Loxitane
PHILADELPHIA — Lannett has received regulatory approval from the Food and Drug Administration for its version of an antipsychotic treatment.
The drug maker said the FDA approved its abbreviated new drug application for loxapine capsules in the 5-mg, 10-mg, 25-mg and 50-mg strengths. The drug is a generic version of Watson Pharmaceuticals' Loxitane.
-
Poll: More Americans endanger health amid tough economy
YONKERS, N.Y. — A growing number of Americans are putting their health at risk in order to save money, according to a new study.
Consumer Reports' annual prescription drug poll found that 48% of respondents currently taking a prescription drug said they'd cut healthcare costs by putting off a doctor's visit or medical procedure, declining tests or ordering drugs from outside the United States — a 9% increase over 2010.